Merger of Paramount and Warner Bros. Discovery is delayed until 2027 due to legal disputes

3 min read
Paramount Foto: Paramount - PJ McDonnell/ Shutterstock.com

Paramount Global has agreed to delay its acquisition of Warner Bros. Discovery for several months, with the agreement potentially extending until 2027. The decision is due to pending lawsuits filed by attorneys general from several American states and the Writers Guild of America – WGA. The postponement frustrates Paramount’s original plan to complete the mega-merger by the end of September, creating a scenario of uncertainty for two of Hollywood’s biggest studios.

New deadline for defining the business

In recently filed court documents, Paramount said it will not complete the merger until an antitrust trial is held or until June 1, 2027, whichever comes first. The current merger agreement between the companies would expire on March 4, but already provided for an automatic extension until June 4, 2027. This postponement means that negotiations and integration of the entertainment giants will remain paralyzed for a considerable period.

Market impact and analyst reaction

News of the postponement resulted in shares of both Paramount and Warner Bros. falling. Discovery (WBD), reflecting market apprehension. While critics of the merger celebrated the delay, industry analysts called the decision a significant setback, raising doubts about the viability of the controversial deal. Paramount, however, described the deal as a “significant victory,” saying it seeks a direct path to an evidence-based trial, which it considers the fastest way to prove the legality and benefits of the transaction.

The legal obstacles that hold back the merger

The main obstacles to completing the merger are the lawsuits filed by a coalition of 12 state attorneys general, in addition to the lawsuit by the Writers Guild of America. The plaintiffs argue that combining the companies would result in reduced competition in the market and harm consumers. Rob Bonta, California’s attorney general, said the goal is to ensure that the merger, which he describes as “illegal,” never comes to fruition, promising to continue to present the case in court.

Next steps in the legal dispute

The recent settlement is the result of discussions between lawyers for all parties involved, eliminating the need for an August 3 hearing on the states’ injunction request and withdrawing a similar motion from the Screenwriters Guild. Lawyers for Paramount concluded that the plaintiffs would likely prevail in the preliminary injunction phase, prompting the company to seek a speedy jury trial. Judge Araceli Martínez-Olguín, responsible for the case, promptly approved the agreement. The parties will now set the timeline for the trial of the underlying antitrust allegations, with a proposal expected soon. Makan Delrahim, Paramount’s chief legal officer, plans to seek a trial date in November, while Attorney General Rob Bonta anticipates the trial request not occurring until 2027.

Costs and disagreements about the future of the business

The delay could result in considerable costs for Paramount. Under the terms of the merger agreement, the company must pay Warner Bros. shareholders. Discovery a “tracking fee” of 25 cents per share each quarter the transaction remains incomplete after September 30. Despite this, Paramount maintains that the transaction is beneficial to competition, consumers and creators. Rich Greenfield, an analyst at Lightshed Research, noted that even with a possible defeat in the District Court, the path to a higher court appeal would be accelerated, with the possibility of reaching the Supreme Court in 2027.

Approvals already obtained in other countries

While the lawsuits in California represent the biggest obstacle, other regulatory authorities have already given their blessing to the merger. The US Department of Justice approved the settlement last month. The European Commission also granted conditional approval, although it required Paramount to make concessions, such as exiting a film distribution joint venture with Universal in Europe. This duality between international approvals and resistance in the United States demonstrates the regulatory complexity of the business.

Carolina Costa é colaboradora da redação do Mix Vale, portal de notícias com cobertura de Brasil e mundo. Produz conteúdo nas editorias de economia e benefícios, com foco em informação de serviço para o leitor brasileiro. Escreve para o portal desde 2019. Formação: Administração

Notícias relacionadas